Autism Linked to Fourfold Increase in Parkinson's Disease
Autism spectrum disorder (ASD) is linked to a fourfold increased risk for early-onset Parkinson's disease (PD), results from the largest, population-based cohort study of its kind to date showed.
The findings indicated 'that there can be shared biological drivers behind ASD and Parkinson's disease,' study investigator, Weiyao Yin, MD, PhD, of the Karolinska Institutet in Stockholm, Sweden, said in a release.
'One hypothesis is that the brain's dopamine system is affected in both cases, since the neurotransmitter dopamine plays an important part in social behavior and motion control,' Yin added.
The study was published online on May 27 in JAMA Neurology .
A Plausible Link
Recent research pointed to a plausible biological link between ASD and PD. However, large, longitudinal studies investigating the risk for PD following an ASD diagnosis are scarce, the researchers noted.
'Our study is the first population-based study, to our knowledge, using prospectively collected data, longitudinal design, and life-course approach to strengthen the inference,' they wrote.
To investigate they used national registry data from more than 2 million individuals born in Sweden between 1974 and 1999 and followed them from age 20 years up to the end of 2022. The median age at study exit was 34 years.
Within this cohort, they identified 51,954 individuals with ASD and 2,226,611 individuals without the disorder.
PD, defined as a first-ever diagnosis of PD or other idiopathic or degenerative parkinsonian disorders, was identified in 438 individuals without ASD (0.02%; 1.3 cases per 100,000 person-years) and in 24 individuals with ASD (0.05%; 3.9 cases per 100,000 person-years), corresponding to a relative risk (RR) of 4.43.
Depression and antidepressant use were present in 46.7% of individuals with ASD, and antipsychotic use, which can cause Parkinson-like symptoms, was present in 31.5%.
Adjusting for depression and antipsychotic use reduced but did not eliminate the association between ASD and PD risk (RR, 3.10 and RR, 2.00, respectively).
Independent of ASD diagnosis, a history of depression and exposure to antipsychotics were linked to a significantly higher risk for PD (RR, 2.01 and RR, 6.34, respectively).
Preterm or early-term birth is a known risk factor for ASD, prompting an examination of its potential association with PD. However, no increased risk for PD was found compared with individuals born at full term.
After adjusting for sex, socioeconomic status, and parental mental illness or PD, the investigators found ASD remained consistently associated with an increased risk for PD.
There are potential biological explanations for the link, Yin told Medscape Medical News .
'One hypothesis suggests that the brain's dopamine system is impacted in both conditions, as the neurotransmitter dopamine plays a crucial role in social behavior and motor control,' Yin said.
There may be a genetic correlation between the two conditions, she added noting that the PARK2 gene may be associated between ASD and early-onset PD.
'ASD is a lifelong condition, and more children with autism now progress into middle and older adulthood. Healthcare services need to provide long-term monitoring for individuals with ASD — a vulnerable group with high comorbidity and a high use of psychotropic medications,' Yin said.
Experts Weigh In
The study is clinically relevant 'mainly because it shows that neurodevelopmental conditions, like ASD, may be associated with clinical signs and diagnoses that may manifest at different ages, and we as clinicians should be aware of that,' Christos Ganos, MD, a neurologist at the Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada, who was not involved with the study, told Medscape Medical News .
'Although neurodevelopmental disorders are diagnosed early in life, there is a need to assess for neurological symptoms and signs also later in life, including to monitor the effects of prescribed medications on neuromotor control,' added Ganos, who is the wolf chair in neurodevelopmental psychiatry, and associate professor of neurology at the University of Toronto, Toronto, Ontario, Canada.
However, he urged caution in linking the specific diagnoses of ASD and PD, as there is a more general link between neurodevelopmental disorders and motor dysfunction.
'Neurodevelopmental disorders are very heterogeneous, and the 'ASD' diagnosis encompasses a lot of different disorders and etiologies. Some of these diagnoses/conditions are linked to motor syndromes that are specifically associated with motor slowing but are not PD, although they could resemble some of its features,' he explained.
Strengths of the study include its large sample size and statistical power to provide estimates 'with more meaningful precision than prior studies,' said Connie Marras, MD, PhD, a movement disorders specialist, and professor of neurology at the University of Toronto.
However, she noted that investigators did not include smoking in the models, which 'may result in an overestimation of the association between ASD and PD,' she added. 'Smoking is less common among individuals with ASD and may constitute a confounder. Smoking is also less common in individuals with Parkinson's disease and is considered a protective factor against PD.'
She also questioned whether the results really have clinical implications for monitoring the emergence of parkinsonism in this population.
'Early detection does not have treatment implications currently, particularly since at present we don't have therapies for PD prevention or slowing of progression. Once we do have such treatments, then monitoring would be justified,' she said.
However, the finding 'could have significant clinical and policy-related implications as these individuals age,' Gregory Wallace, PhD, an autism expert and associate professor of speech, language, and hearing sciences at The George Washington University, Washington, DC, who was not part of the study, told Medscape Medical News.
'Given increased rates of autism diagnoses in younger cohorts, if autistic people are at increased risk for developing parkinsonism as they age, the healthcare system and clinicians who provide care for autistic adults need to be prepared,' said Wallace.
Wallace recently published research showing that co-occurring parkinsonism in adults with autism is linked with lower subjective quality of life, more memory problems, lower sleep quality, and greater depression symptoms.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Nobel Biocare and 3Shape Announce Strategic Distribution Partnership
Nobel Biocare to Distribute 3Shape TRIOS® Intraoral Scanners ZURICH, June 23, 2025 /PRNewswire/ -- Nobel Biocare is pleased to announce a new distribution partnership with 3Shape, a global leader in 3D scanning and digital dental solutions. Through this collaboration, Nobel Biocare will become an official distributor of 3Shape's TRIOS® intraoral scanners, expanding its digital dentistry portfolio and delivering even greater value to dental professionals worldwide. 3Shape's TRIOS® scanners are widely recognized for their accuracy, ease of use, and patient-friendly scanning experience. This distribution agreement brings together 3Shape's innovative scanning technology with Nobel Biocare's trusted heritage in implant-based restorations and prosthetics, offering customers a streamlined digital workflow from scan to final restoration. At the same time, we would like to emphasize that the DEXIS IS scanner remains a core element of our offering — an enduring symbol of our strong and strategic partnership with DEXIS. This dual approach not only enhances the range of cutting-edge tools available to dental professionals but also reaffirms our pledge to quality care and innovation, instilling confidence among our customers and key stakeholders, including our valued Envista investors. "At Nobel Biocare, our mission is to redefine what is possible in Dental care by empowering clinicians through innovation" said Rosemary O'Neill, VP/GM Procera and Digital Solutions "By partnering with 3Shape and distributing TRIOS scanners, we're enabling our customers to access one of the most advanced intraoral scanning solutions available, supported by Nobel Biocare's expertise and service network." Key benefits of the partnership include: Seamless integration of TRIOS scanners with Nobel Biocare's digital workflows Bringing together two premium brands to deliver treatment efficiencies, predictability and reduced time to teeth - transforming patients lives through our superior products and solutions Access to world-class training and educational resources to ensure clinical success "We are excited to collaborate with Nobel Biocare to expand access to TRIOS," said John Cusack, Chief Commercial Officer at 3Shape. "This partnership ensures more dental professionals can benefit from a proven digital solution that enhances patient care and practice efficiency." TRIOS scanners will be available in select markets for purchase through Nobel Biocare by end June 2025. For more information, please contact your local Nobel Biocare representative. About Nobel BiocareNobel Biocare is a world leader in implant-based dental restorations. Our mission is to empower dental professionals to provide exceptional care through innovative solutions and clinical support. About 3Shape3Shape is a global innovator in digital dentistry, empowering dental professionals to provide superior dental care for every patient, every time. Its award-winning digital solutions advance and connect practices and labs. Founded in Denmark in 2000, 3Shape employs more than 2,200 dedicated professionals, who together serve customers in 100+ countries. Private equity fund EQT has been a shareholder since 2022. For more information, visit Media contact: Lauren View original content to download multimedia: SOURCE Nobel Biocare Sign in to access your portfolio
Associated Press
24 minutes ago
- Associated Press
Nobel Biocare and 3Shape Announce Strategic Distribution Partnership
Nobel Biocare to Distribute 3Shape TRIOS® Intraoral Scanners ZURICH, June 23, 2025 /PRNewswire/ -- Nobel Biocare is pleased to announce a new distribution partnership with 3Shape, a global leader in 3D scanning and digital dental solutions. Through this collaboration, Nobel Biocare will become an official distributor of 3Shape's TRIOS® intraoral scanners, expanding its digital dentistry portfolio and delivering even greater value to dental professionals worldwide. 3Shape's TRIOS® scanners are widely recognized for their accuracy, ease of use, and patient-friendly scanning experience. This distribution agreement brings together 3Shape's innovative scanning technology with Nobel Biocare's trusted heritage in implant-based restorations and prosthetics, offering customers a streamlined digital workflow from scan to final restoration. At the same time, we would like to emphasize that the DEXIS IS scanner remains a core element of our offering — an enduring symbol of our strong and strategic partnership with DEXIS. This dual approach not only enhances the range of cutting-edge tools available to dental professionals but also reaffirms our pledge to quality care and innovation, instilling confidence among our customers and key stakeholders, including our valued Envista investors. 'At Nobel Biocare, our mission is to redefine what is possible in Dental care by empowering clinicians through innovation' said Rosemary O'Neill, VP/GM Procera and Digital Solutions 'By partnering with 3Shape and distributing TRIOS scanners, we're enabling our customers to access one of the most advanced intraoral scanning solutions available, supported by Nobel Biocare's expertise and service network.' Key benefits of the partnership include: 'We are excited to collaborate with Nobel Biocare to expand access to TRIOS,' said John Cusack, Chief Commercial Officer at 3Shape. 'This partnership ensures more dental professionals can benefit from a proven digital solution that enhances patient care and practice efficiency.' TRIOS scanners will be available in select markets for purchase through Nobel Biocare by end June 2025. For more information, please contact your local Nobel Biocare representative. About Nobel Biocare Nobel Biocare is a world leader in implant-based dental restorations. Our mission is to empower dental professionals to provide exceptional care through innovative solutions and clinical support. About 3Shape 3Shape is a global innovator in digital dentistry, empowering dental professionals to provide superior dental care for every patient, every time. Its award-winning digital solutions advance and connect practices and labs. Founded in Denmark in 2000, 3Shape employs more than 2,200 dedicated professionals, who together serve customers in 100+ countries. Private equity fund EQT has been a shareholder since 2022. For more information, visit Media contact: Lauren Meinhardt [email protected] View original content to download multimedia: SOURCE Nobel Biocare
Health Line
an hour ago
- Health Line
The Benefits of Kettlebell Swings and How to Do Them Right
Kettlebell swings are a high intensity, low impact exercise that works the muscles of your upper and lower body and your midsection. They can help you improve your cardiovascular fitness and strength. Over the past decade, kettlebell swings have grown in popularity as a quick full-body workout. Originating in Russia, kettlebells (called girya in Russian) are associated with great power and strength. People originally used them to measure against the weight of various goods but eventually used them in strength competitions. Nowadays, they're popular in workout programs such as CrossFit and athletic training programs. Because they're convenient and relatively simple to use, they're also common in high intensity exercise plans for the average person. What are the benefits of using a kettlebell? Potential benefits of kettlebell swings include: Better cardiorespiratory fitness: Kettlebell swings involve your whole body, which requires your heart to beat faster to pump blood throughout your body. Stronger posterior chain: Kettlebell swings target your upper and lower back, glutes, and hamstrings, known collectively as the posterior chain. Full-body workout: Kettlebell swings use your upper body, core, and lower body for an excellent full-body workout. Powerful calorie burn: Kettlebell workouts are high intensity and can burn a lot of calories in a short time. You may burn more calories after the workout due to post-exercise oxygen consumption, which is a temporary increase in metabolism to support recovery. Quick and convenient exercise: Most kettlebell workouts only require a kettlebell. The duration and type of workout can vary based on a person's needs. Low impact exercise: Kettlebells keep your feet planted on the ground, reducing force and pressure on your knees. For some people, this may be a better option for getting the heart pumping than higher impact exercises such as jump training. What muscles do kettlebell swings work? Kettlebell swings are a full-body workout because they target muscles of the upper body, lower body, and core. In particular, kettlebell swings target muscles of the posterior chain, which includes the: glutes hamstrings calves erector spinae trapezius (traps) rhomboids You may also notice some activation of your abdominals, quadriceps, anterior deltoids, pectorals, and forearm muscles — which are considered part of the anterior chain (front of the body). In addition, kettlebell swings can help improve your grip strength. How to do a proper kettlebell swing To get the most out of your workout and reduce your risk of injury, it's important to learn how to properly swing a kettlebell. Here's how to do it: Stand with your feet shoulder-width apart while holding a kettlebell with both hands (palms facing toward you) and arms straight down. Inhale and push your hips back (hinge your hips) and slightly bend your knees to bring the kettlebell between your legs. Keep your back straight and engage your core. Exhale, contract your glutes, and push your hips forward to lift your body into a standing position. Allow your arms to swing the kettlebell as far as they will naturally go. Your goal is shoulder height or parallel to the ground, although you do not want to use arm strength to raise the kettlebell. It may take a few swings to find your rhythm and maximize the lift. Inhale and lower the kettlebell between your legs by pushing your hips back and slightly bending your knees. This is one rep. Perform two to three sets of 10 to 20 reps, or continue for your preferred time (e.g., as many as you can do in five minutes). It's important to focus on proper form throughout this movement to prevent lower back injury. Most of the force should come from your legs and glutes, not your shoulders and arms. Focusing on the hip-hinge movement during the lowering phase will allow you to safely build power and momentum. Do not abruptly stop the exercise, which may lead to injury. Instead, slowly reduce the speed and power of your swings until you can safely stop. Beginners may benefit from speaking with a fitness professional before trying kettlebells to ensure they are a suitable exercise. A professional can help with proper form and weight, and recommend new types of swings to progress to. Common mistakes when doing kettlebell swings While kettlebell swings can be an effective and safe exercise, the following mistakes may slow your results and potentially lead to injury: Lifting with your arms: The power and momentum from your lower body should drive the kettlebell up. Your arms should simply guide the kettlebell, not do the heavy lifting. Rounding your back: Rounding your back and shoulders during the lowering phase can put excess strain on your lower back, leading to an injury. Keep your upper back and shoulder muscles strong to resist the pull of gravity. Squatting: The kettlebell swing relies on a hip-hinge movement to swing the kettlebell up and in front of your body. Squatting puts more attention on your quadriceps and produces less power. Bending your knees too much: This can result in a squatting movement, which will not produce as much power and momentum. Not engaging your core: To prevent lower back injury and support the movement, keep your core engaged throughout the exercise. Swinging too fast: Kettlebell swings involve intentional, controlled movements. Moving too quickly will place more focus on your upper body because you're not giving your lower body enough time to generate force. This may also lead to injury. Using the wrong weight: The kettlebell should be heavy enough to provide a challenge but not so heavy that you can't lift it and compromise your form. It's best to gradually increase the weight once you perfect your form to improve strength. Forgetting to breathe: Focus on inhaling as you hinge and exhaling as you push. As you learn to swing a kettlebell, remember to keep these common mistakes at the top of your mind. How to pick the right weight for a kettlebell swing Kettlebell weights can range from 4.4 to 202.8 pounds (2 to 92 kilograms). Choosing the right kettlebell weight will depend on your strength and experience, and the type of workout you want to do. Kettlebell swings usually do not involve kettlebells that weigh over 70 pounds (31.7 kilograms). If you're a beginner, it's best to choose a lighter kettlebell. This will allow you to practice the swing movement with proper form, reducing the risk of injury. As you perfect your form and get stronger, you may wish to increase your kettlebell weight.
